Nov. 28 (Bloomberg) -- The first drug tests conducted at an international golf championship all produced negative results, top officials of the two organizers said today.

The tests at last month's World Amateur Team Championships in Stellenbosch, South Africa, failed to find any signs of steroids or recreational drugs, U.S. Golf Association Executive Director David Fay and Royal & Ancient Golf Club Secretary Peter Dawson said today.

Golf has come under pressure to take anti-drug action since players started routinely hitting 300-yard drives in recent years. The LPGA Tour said this month it would be the first major pro golf circuit to test for drugs, and the U.S. PGA Tour said it would compile a list of banned performance-enhancers.

``I am pleased to be able to tell you that all test results from the World Amateur Team Championships were negative,'' Dawson said in an e-mail. ``There were no failed tests.''

The tested golfers -- six men and six women -- were picked at random from the 70 male and 39 female teams of three golfers each at the championships, Fay said.

``You are relieved when the results all come back negative,'' Fay said in a telephone interview from his office in Far Hills, New Jersey. ``But there was a high degree of education. These players were made aware there would be a random test and it confirms for these two championships that we're clean.''

The tests were conducted by the South African Institute for Drug Free Sport following guidelines set by the World Anti- Doping Agency, Fay said. The women's championship was held Oct. 18-21, and the men's Oct. 26-29.

The LPGA, the world's leading women's golf circuit, will begin drug testing in 2008, becoming the only golf tour in the world to test its athletes without a government mandate.

The PGA Tour said it will create a list of banned substances and start informing players about their effects and the penalties of drug use. The world's richest tour only tests golfers if the commissioner or a player has reason to believe someone is using banned substances.

To contact the reporter on this story: Curtis Eichelberger in Washington at ceichelberge@bloomberg.net

Last Updated: November 28, 2006 15:04 EST